The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer

被引：0
作者：
Mihailovic, Jasna [1 ,2 ]
Ubavic, Milan [3 ,4 ]
机构：
[1] Oncol Inst Vojvodina, Dept Nucl Med, Put Dr Goldmana 4, Sremska Kamenica 21000, Serbia
[2] Univ Novi Sad, Tech Fac Mihajlo Pupin, Zrenjanin, Serbia
[3] Univ Novi Sad, Lab Diagnost Medlab, Hlth Care Inst, Novi Sad, Serbia
[4] European Univ, Fac Pharm, Novi Sad, Serbia
来源：
VOJNOSANITETSKI PREGLED | 2017年 / 74卷 / 06期
关键词：
breast neoplasms; tomography; emission-computed; x-ray computed; radiopharmaceuticals; sensitivity and specificity; STANDARDIZED UPTAKE VALUES; LYMPH-NODE BIOPSY; F-18; FDG-PET; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; INITIAL-EXPERIENCE; GLUCOSE-METABOLISM; BONE METASTASES; RECEPTOR STATUS; EARLY RESPONSE;
D O I：
10.2298/VSP151018110M
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 580
页数：10
相关论文
共 83 条
[1]   18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer [J].
Alberini, Jean-Louis ;
Lerebours, Florence ;
Wartski, Myriam ;
Fourme, Emmanuelle ;
Le Stanc, Elise ;
Gontier, E. ;
Madar, O. ;
Cherel, P. ;
Pecking, A. P. .
CANCER, 2009, 115 (21) :5038-5047
[2]   Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer? [J].
Andrade, W. P. ;
Lima, E. N. P. ;
Osorio, C. A. B. T. ;
do Socorro Maciel, M. ;
Baiocchi, G. ;
Bitencourt, A. G. V. ;
Fanelli, M. F. ;
Damascena, A. S. ;
Soares, F. A. .
EJSO, 2013, 39 (12) :1358-1363
[3]  
[Anonymous], CANC INC MORT CENTR
[4]   The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques [J].
Aukema, T. S. ;
Rutgers, E. J. Th. ;
Vogel, W. V. ;
Teertstra, H. J. ;
Oldenburg, H. S. ;
Peeters, M. T. F. D. Vrancken ;
Wesseling, J. ;
Russell, N. S. ;
Olmos, R. A. Valdes .
EJSO, 2010, 36 (04) :387-392
[5]   Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations [J].
Avril, N ;
Rosé, CA ;
Schelling, M ;
Dose, J ;
Kuhn, W ;
Bense, S ;
Weber, W ;
Ziegler, S ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3495-3502
[6]   Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose [J].
Avril, N ;
Dose, J ;
Janicke, F ;
Bense, S ;
Ziegler, S ;
Laubenbacher, C ;
Romer, W ;
Pache, H ;
Herz, M ;
Allgayer, B ;
Nathrath, W ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1848-1857
[7]   Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose [J].
Avril, N ;
Dose, J ;
Janicke, F ;
Ziegler, S ;
Romer, W ;
Weber, W ;
Herz, M ;
Nathrath, W ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1204-1209
[8]  
Avril N, 2001, J NUCL MED, V42, P9
[9]   Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters [J].
Basu, Sandip ;
Chen, Wengen ;
Tchou, Julia ;
Mavi, Ayse ;
Cermik, Tevfik ;
Czerniecki, Brian ;
Schnall, Mitchell ;
Alavi, Abass .
CANCER, 2008, 112 (05) :995-1000
[10]  
Baum RP, 2001, Q J NUCL MED, V45, P257
123456789